ClinicalTrials.govpublic full text
Adding IL-2 to Tebentafusp to Eradicate Cancer Progression
uveal melanoma, metastatic uveal melanoma, metastatic uveal melanoma in the liver, immunotherapy, treatment resistance, combinational immunotherapy, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 900674
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.